Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa
- PMID: 6090843
- DOI: 10.1016/0024-3205(84)90179-6
Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa
Abstract
Synthetic atrial natriuretic factor (ANF) inhibited aldosterone production by suspensions of bovine adrenal glomerulosa cells. Inhibition by ANF was most pronounced when basal aldosterone production was measured. The effects of angiotensin II (AII), N6,O2'-dibutyryl-adenosine 3':5'-cyclic monophosphate (dibutyryl cyclic AMP), and elevated potassium were also inhibited by ANF. Inhibition could be partially overcome by high doses of agonist. Inhibition was localized to the early pathway of aldosteronogenesis, to a step before cholesterol side-chain cleavage. ANF had no effect on binding of AII to receptors, on the stimulation by AII of phospholipid turnover, or on the alteration by AII of calcium fluxes.
Similar articles
-
Effects of angiotensin II and dibutyryl cyclic adenosine monophosphate on phosphatidylinositol metabolism, 45Ca2+ fluxes, and aldosterone synthesis in bovine adrenal glomerulosa cells.Life Sci. 1983 Oct 31;33(18):1771-8. doi: 10.1016/0024-3205(83)90684-7. Life Sci. 1983. PMID: 6316048
-
Participation of voltage-dependent calcium channels in the regulation of adrenal glomerulosa function by angiotensin II and potassium.Endocrinology. 1986 Jan;118(1):112-8. doi: 10.1210/endo-118-1-112. Endocrinology. 1986. PMID: 2416549
-
Effects of atrial natriuretic peptide, angiotensin, cyclic AMP, and potassium on protein phosphorylation in adrenal glomerulosa cells.Life Sci. 1987 Dec 7;41(23):2517-24. doi: 10.1016/0024-3205(87)90436-x. Life Sci. 1987. PMID: 2824959
-
Inhibition of aldosterone synthesis by atrial natriuretic factor.Fed Proc. 1986 Aug;45(9):2376-81. Fed Proc. 1986. PMID: 3015692 Review.
-
Angiotensin II receptors and mechanisms of action in adrenal glomerulosa cells.J Steroid Biochem. 1987;27(4-6):915-27. doi: 10.1016/0022-4731(87)90168-3. J Steroid Biochem. 1987. PMID: 2826911 Review.
Cited by
-
Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics.Front Mol Neurosci. 2023 Jan 4;15:1076799. doi: 10.3389/fnmol.2022.1076799. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36683859 Free PMC article. Review.
-
MANP Activation Of The cGMP Inhibits Aldosterone Via PDE2 And CYP11B2 In H295R Cells And In Mice.Hypertension. 2022 Aug;79(8):1702-1712. doi: 10.1161/HYPERTENSIONAHA.121.18906. Epub 2022 Jun 8. Hypertension. 2022. PMID: 35674049 Free PMC article.
-
Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.J Endocrinol Invest. 2004 Oct;27(9):844-53. doi: 10.1007/BF03346279. J Endocrinol Invest. 2004. PMID: 15648549
-
The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.Heart Fail Rev. 2003 Jan;8(1):55-70. doi: 10.1023/a:1022147005110. Heart Fail Rev. 2003. PMID: 12652160 Review.
-
Ultracytochemical localization of particulate guanylate cyclase in rat adrenal gland exposed to stimulation by porcine brain natriuretic peptide.Histochem J. 1993 May;25(5):384-91. doi: 10.1007/BF00159503. Histochem J. 1993. PMID: 8100560
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
